{
    "clinical_study": {
        "@rank": "60315", 
        "arm_group": {
            "arm_group_label": "Children suspected of allergic diseases", 
            "description": "Children suspected of allergic diseases No intervention"
        }, 
        "biospec_descr": {
            "textblock": "IgE specific allergen antibodies"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The aim of this study is to assess the influence of kind of allergic disease, allergic\n      profile, allergen exposure, treatment method on lung function parameters, fractional exhaled\n      nitric oxide level in children suspected and being diagnosed due to allergic diseases."
        }, 
        "brief_title": "PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Asthma", 
            "Allergic Rhinitis", 
            "Atopic Dermatitis", 
            "Urticaria", 
            "Healthy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Asthma", 
                "Dermatitis", 
                "Dermatitis, Atopic", 
                "Rhinitis", 
                "Urticaria"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of this study is to assess the influence of kind of allergic disease, allergic\n      profile, allergen exposure, treatment method on lung function parameters, fractional exhaled\n      nitric oxide (FeNO) level in children suspected and being diagnosed due to allergic\n      diseases.\n\n      Study will be retrospective, conducted in all children diagnosed in the years of 2005-20012\n      in Laboratory of lung function tests of Department of Pediatrics and Allergy, Medical\n      University of Lodz, N. Copernicus Hospital, Lodz, Poland. The investigators will analyse\n      5500 male an female children 5-18 year old suspected and being diagnosed due to allergic\n      diseases. In these children nearly 3000 FeNO measurements, 65000 spirometry measurements,\n      22000 whole-body plethysmography measurements and 48000 occlusion resistance measurements\n      were performed between the years  of 2005-2012.\n\n      The investigators  will retrospectively evaluate following data from medical documentation\n      of patients:\n\n        1. FeNO levels.\n\n        2. Allergic disease diagnosis.\n\n        3. Immunoglobulin E (IgE) specific levels.\n\n        4. Treatment (drugs and dosages).\n\n        5. Lung function parameters (spirometry, whole-body plethysmography, occlusion resistance,\n           bronchial reversibility test)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children with allergic diseases, healthy children.\n\n        Exclusion Criteria:\n\n          -  Other serious diseases."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "18 Years", 
            "minimum_age": "5 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Children with allergic diseases, healthy children."
            }
        }, 
        "enrollment": {
            "#text": "5500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01805635", 
            "org_study_id": "RNN/23/13/KE"
        }, 
        "intervention": {
            "arm_group_label": "Children suspected of allergic diseases", 
            "description": "No intervention", 
            "intervention_name": "No intervention", 
            "intervention_type": "Other", 
            "other_name": "No intervention"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Children", 
            "Asthma", 
            "Allergic rhinitis", 
            "Atopic dermatitis", 
            "Urticaria", 
            "Healthy"
        ], 
        "lastchanged_date": "September 6, 2013", 
        "location": {
            "contact": {
                "email": "alergol@kopernik.lodz.pl", 
                "last_name": "Iwona Stelmach, MDPhDProf", 
                "phone": "48426895972"
            }, 
            "contact_backup": {
                "email": "alergol@kopernik.lodz.pl", 
                "last_name": "Tomasz Grzelewski, MDPhD", 
                "phone": "48426895972"
            }, 
            "facility": {
                "address": {
                    "city": "Lodz", 
                    "country": "Poland", 
                    "zip": "93-513"
                }, 
                "name": "Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluation of the Relationship Between the Parameters of Pulmonary Function (PF) and the Concentration of Fractional Exhaled Nitric Oxide (FeNO) and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases", 
        "other_outcome": [
            {
                "description": "Fractional exhaled nitric oxide (Sievers equipment)", 
                "measure": "Fractional exhaled nitric oxide (FeNO)", 
                "safety_issue": "No", 
                "time_frame": "7 years"
            }, 
            {
                "description": "Immunoglobulin E (IgE) allergen specific (ELISA method)", 
                "measure": "Immunoglobulin E (IgE) allergen specific", 
                "safety_issue": "No", 
                "time_frame": "7 years"
            }, 
            {
                "description": "Treatment of asthma (drugs and dosages last 3 months before measurement of lung function parameters and FeNO)", 
                "measure": "Treatment of asthma (drugs and dosages)", 
                "safety_issue": "No", 
                "time_frame": "7 years"
            }
        ], 
        "overall_contact": {
            "email": "alergol@kopernik.lodz.pl", 
            "last_name": "Iwona Stelmach, MDPhDProf", 
            "phone": "48426895972"
        }, 
        "overall_contact_backup": {
            "email": "alergol@kopernik.lodz.pl", 
            "last_name": "Tomasz Grzelewski, MD PhD", 
            "phone": "48426895972"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland", 
                "last_name": "Iwona Stelmach, MDPhDProf", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland", 
                "last_name": "Tomasz Grzelewski, MDPhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Allergic disease diagnosis. The diagnosis and the severity of asthma, allergic rhinitis and atopic dermatitis and other allergic diseases universally established by the doctors (allergologists) according to standard definitions of  diseases in the latest guidelines", 
            "measure": "Allergic disease diagnosis", 
            "safety_issue": "No", 
            "time_frame": "7 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01805635"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical Universtity of Lodz", 
            "investigator_full_name": "Iwona Stelmach", 
            "investigator_title": "MDPhDProf", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "spirometry, whole-body pletysmography, occlusion resistance, bronchial reversibility test", 
            "measure": "Lung function (LF)", 
            "safety_issue": "No", 
            "time_frame": "7 years"
        }, 
        "source": "Medical Universtity of Lodz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical Universtity of Lodz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}